Finance

Lists
506690:BOM
Unichem Laboratories Ltd
₹512,75
-1,41%
(-7,35) 1D
16 Okt., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 506690...
Open
₹520,60
High
₹521,65
Low
₹505,00
Mkt. cap
35,95 mjd
Avg. vol.
12,66 k
Volume
2,22 k
P/E ratio
11,86
52-wk high
₹685,95
52-wk low
₹280,00
EPS
₹43,22
Shares outstanding
70,38 m
No. of employees
3 k
Open
₹520,60
High
₹521,65
Low
₹505,00
Mkt. cap
35,95 mjd
Avg. vol.
12,66 k
Volume
2,22 k
P/E ratio
11,86
52-wk high
₹685,95
52-wk low
₹280,00
EPS
₹43,22
Shares outstanding
70,38 m
No. of employees
3 k
News stories
From web sources and news partners
Profile
Unichem Laboratories is an Indian pharmaceutical company, headquartered in Mumbai. It manufactures and markets pharmaceutical formulations across the globe, including the regulated markets of the USA and Europe. Wikipedia
About Unichem Laboratories Ltd
CEO-
Employees2,78 k
Founded1944
HeadquartersMumbai, Maharashtra, Indië
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
5,79 mjd
5,21 mjd
5,75 mjd
6,33 mjd
Cost of goods sold
2,70 mjd
2,37 mjd
3,41 mjd
2,89 mjd
Cost of revenue
2,70 mjd
2,37 mjd
3,41 mjd
2,89 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,00 mjd
992,70 m
1,05 mjd
1,03 mjd
Operating expense
2,74 mjd
2,71 mjd
2,10 mjd
3,04 mjd
Total operating expenses
5,44 mjd
5,08 mjd
5,50 mjd
5,93 mjd
Operating income
347,10 m
135,30 m
246,30 m
400,00 m
Other non operating income
209,70 m
118,00 m
-389,10 m
156,10 m
EBT including unusual items
-108,20 m
2,93 mjd
187,90 m
489,90 m
EBT excluding unusual items
474,40 m
179,10 m
271,70 m
489,90 m
Income tax expense
10,70 m
291,40 m
78,80 m
75,20 m
Effective tax rate
-9,89%
9,93%
41,94%
15,35%
Other operating expenses
1,42 mjd
1,40 mjd
743,50 m
1,71 mjd
Net income
-118,90 m
2,64 mjd
109,10 m
414,70 m
Net profit margin
-2,05%
50,71%
1,90%
6,56%
Earnings per share
-
-
-
-
Interest and investment income
-
-
53,00 m
-
Interest expense
-82,40 m
-74,20 m
-92,80 m
-66,20 m
Net interest expenses
-82,40 m
-74,20 m
-39,80 m
-66,20 m
Depreciation and amortization charges
314,70 m
312,50 m
306,10 m
299,40 m
EBITDA
663,40 m
428,72 m
541,10 m
694,80 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme